Update on surgical removal of choroidal neovascularization

Current Opinion in Ophthalmology

Volumn 11, Issue 3, 2000, Pages 180-185

  Rao, P Kumar ^a   Thomas, Matthew A ^a  

^a BARNES RETINA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; OCULAR HISTOPLASMOSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

CHOROIDAL NEOVASCULARIZATION; HUMANS; LASER SURGERY; OPHTHALMOLOGIC SURGICAL PROCEDURES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0034096860     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200006000-00005     Document Type: Article

References (49)

1. 1 Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group: Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of two randomized clinical trials-TAP Report 1. Arch Ophthalmol 1999, 117:1329-1345.
2. This report details the initial encouraging results of a randomized clinical trial for photodynamic therapy. 2 Macular Photocoagulation Study Group: Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 1990, 108:825-831.
3. 3 Macular Photocoagulation Study Group: Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1991, 109:1232-1241.
4. 4 Freund KB, Yannuzzi LA, Sorenson JA: Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993, 115:786-791.
5. 5 Moisseiev JA, Masuri R, Treister G: The impact of the Macular Photocoagulation Study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol 1995, 113:185-189.
6. 6 de Juan E, Machemer R: Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988, 105: 25-29.
7. 7 Blinder KJ, Peyman GA, Paris CL, Gremillion CM: Submacular scar excision in age-related macular degeneration. Int Ophthalmol 1991, 15:215-222.
8. 8 Thomas MA, Kaplan HJ: Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol 1991, 111:1-7.
9. 9 Holekamp NM, Thomas MA, Dickinson JD, Valluri S: Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results. Ophthalmology 1997, 104:22-26.
10. 10 Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS: Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994, 101:1384-1396.
11. 11 Loewenstein A, Rader RS, Shelley TH, De Juan E: A flexible infusion microcannula for subretinal surgery. Ophthalmic Surg Lasers 1997, 28:774-775.
12. 12 Gass JD: Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994, 118:285-298.
13. 13 Grossniklaus HE, Gass JD: Clinicopathologic correlations of surgically excised Type 1 and Type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 1998, 126:59-69. Ten surgically excised membranes were histologically classified as type 1 (beneath the retinal pigment epithelium) or type 2 (between sensory retina and retinal pigment epithelium). Preoperative clinical data were reviewed in a masked fashion, and the membranes were clinically classified as type 1 or type 2. Good correlation existed between the histologic and clinical characterization of these membranes.
14. 14 Ibanez HE, Thomas MA: Surgical approach to subfoveal neovascularization and submacular hemorrhage. Semin Ophthalmol 1994, 9:56-64.
15. 15 Giovannini A, Mariotti C, Scassellati-Sforzolini B, D'Altobrando E: Usefulness of fluorescein angiography in predicting the size of the atrophic area after surgical excision of choroidal neovascularization. Ophthalmologica 1999, 213:139-144. Angiography is useful in predicting the size of this postoperative defect, which was was generally greater in patients with AMD than in those with multifocal choroidopathies or idiopathic CNVM. In AMD, the area of the CNVM and the hyperfluorescent halo seen in the late phase of the angiogram before surgery is only approximately 84% the size of the postoperative defect.
16. 16 Giovannini A, Amato GP, Mariotti C, Scassellati-Sforzolini B: OCT imaging of choroidal neovascularization and its role in the determination of patients' eligibility for surgery. Br J Ophthalmol 1999, 83:438-442. Ocular coherence tomography (OCT) was used to determine the position of the CNVM and good results (gain of two lines of vision) in eyes that underwent excision of a membrane that was shown to be anterior to the RPE by OCT are reported.
17. 17 Melberg NS, Thomas MA, Burgess DB: The surgical removal of subfoveal choroidal neovascularization: ingrowth site as a predictor of visual outcome. Retina 1996, 16:190-195.
18. 18 Bottoni F, Perego E, Airaghi P, et al.: Surgical removal of subfoveal choroidal neovascular membranes in high myopia. Graefes Arch Clin Exp Ophthalmol 1999, 237:573-582.
19. 19 Merrill PT, LoRusso FJ, Lomeo MD, Saxe SJ, Khan MM, Lambert HM: Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology 1999, 106:782-789.
20. 20 Chen CJ, Urban LL, Nelson NC, Fratkin JD: Surgical removal of subfoveal iatrogenic choroidal neovascular membranes. Ophthalmology 1998, 105: 1606-1611.
21. 21 Berger AS, Conway M, Del Priore LV, Walker RS, Pollack JS, Kaplan HJ: Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol 1997, 115: 991-996.
22. 22 Thomas MA, Grand MG, Williams DF, Lee CF, Pesin SR, Lowe MA: Surgical management of subfoveal choroidal neovascularization. Ophthalmology 1992, 99:952-968.
23. 23 Berger AS, Kaplan HJ: Clinical experience with the surgical removal of subfoveal neovascular membranes. Ophthalmology 1992, 99:969-976.
24. 24 Oslen TW, Capone A, Sternberg P, Grossniklaus H, Martin DF, Aaberg TM: Subfoveal choroidal neovascularization in punctate inner choroidopathy: surgical management and pathologic findings. Ophthalmology 1996, 103: 2061-2069.
25. 25 Loewenstein A, Sunness JS, Bressler NM, Marsh MJ, de Juan E: Scanning laser ophthalmoscope fundus perimetry after surgery for choroidal neovascularization. Am J Ophthalmol 1998, 125:657-665.
26. 26 Roth DB, Downie AA, Charles ST: Visual results after submacular surgery for neovascularization in age-related macular degeneration. Ophthalmic Surg Lasers 1997, 28:920-925.
27. 27 Lambert HM, Capone A, Aaberg T, Sternberg P, Mandell BA, Lopez PF: Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1991, 113:257-262.
28. 28 Green WR, Enger C: Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993, 100: 1519-1535.
29. 29 Ormerod LD, Puklin JE, Frank RN: Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration. Ophthalmology 1994, 101:1201-1210.
30. 30 Akduman L, Del Priore LV, Desai VN, Olk RJ, Kaplan HJ: Perfusion of the subfoveal choriocapillaris affects visual recovery after submacular surgery in presumed ocular histoplasmosis syndrome. Am J Ophthalmol 1997, 123:90-96.
31. 31 Castellarin AA, Nasir M, Sugino IK, Zarbin MA: Progressive presumed choriocapillaris atrophy after surgery for age-related macular degeneration. Retina 1998, 18:143-149.
32. 32 Bennett SR, Folk JC, Blodi CF, Klugman M: Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 1990, 109: 33-37.
33. 33 Berrocal MH, Lewis ML, Flynn HW: Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996, 122:486-493.
34. 34 Avery RL, Fekrat S, Hawkins BS, Bressler NM: Natural history of subfoveal hemorrhage in age-related macular degeneration. Retina 1996, 16:183-189.
35. 35 Ibanez HE, Williams DF, Thomas MA, et al.: Surgical management of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol 1995, 113:62-69.
36. 36 Lewis H: Intraoperative fibriolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1999, 118:559-568.
37. 37 Lim JI, Drews-Botsch C, Sternberg P Jr, Capone A, Aaberg TM: Submacular hemorrhage removal. Ophthalmology 1995, 102:1393-1399.
38. 38 Kamei M, Tano Y, Maeno T, Mitsuda H, Yuasa T: Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996, 121:267-275.
39. 39 Hochman MA, Seery CM, Zarbin MA: Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol 1997, 42:195-213.
40. 40 Petersen J, Meyer-Riemann W, Ritzau-Tondrow U, Bahlmann D: Visual fields after removal of subretinal hemorrhages and neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1998, 236: 241-247.
41. 41 Adelberg DA, Del Priore LV, Kaplan HJ: Surgery for subfoveal membranes in myopia, angioid streaks and other disorders. Retina 1995, 15:198-205.
42. 42 Berger AS, McCuen BW, Brown GC, Brownlow RL: Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Retina 1997, 17:94-98.
43. 43 Sears J, Capone A, Aaberg T, et al.: Surgical management of subfoveal neovascularization in children. Ophthalmology 1999, 106:920-924. A retrospective study of 12 children with CNV who benefited from submacular surgery. The authors suggest that surgery is indicated for children with CNVM who demonstrate worsening of visual acuity, protracted neurosensory detachment with cystoid macular edema, or subfoveal hemorrhage.
44. 44 Uemura A, Thomas MA: Visual outcome after surgical removal of choroidal neovascularization in pediatric patients, Arch Ophthalmol 2000, in press.
45. 45 Macular Photocoagulation Study Group: Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1991, 109:1220-1221.
46. 46 Joseph DP, Thomas MA: Surgical treatment of juxtafoveal choroidal neovascularization. Ophthalmol 2000, submitted for publication.
47. 47 Atebara NH, Thomas MA, Holekamp NM, Mandell BA, Del Priore LV: Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Ophthalmology 1998, 105: 1598-1605. This retrospective review of patients with peripapillary CNV due to POHS shows some benefit of surgical intervention. Seventeen eyes were included in this small series. In those eyes with a membrane that was also subfoveal (14 cases) the median preoperative visual acuity was 20/200. Median postoperative visual acuity was 20/40 at the final follow-up visit.
48. 48 Benson MT, Callear A, Tsaloumas M, Chhina J, Beatty S: Surgical excision of subfoveal neovascular membranes. Eye 1998, 12:768-774. Forty-three eyes that underwent surgical excision of CNVM not associated with AMD are reviewed in this report. Seventy-nine percent of the patients had improved or stable visual acuity. Recurrence was noted in 23% of cases. The authors conclude that surgical excision of non-AMD related CNVM may be beneficial.
49. 49 Melberg NS, Thomas MA, Dickinson JD, Valluri S: Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. Ophthalmology 1996, 103:1064-1068.